Does ENZALUTAMIDE Cause Vitreous floaters? 24 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Vitreous floaters have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
24
Reports of Vitreous floaters with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Vitreous floaters From ENZALUTAMIDE?
Of the 24 reports, 6 (25.0%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Vitreous floaters Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which ENZALUTAMIDE Alternatives Have Lower Vitreous floaters Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE